000 01334 a2200433 4500
005 20250515100304.0
264 0 _c20080110
008 200801s 0 0 eng d
022 _a1462-0332
024 7 _a10.1093/rheumatology/kem313
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAntonelli, A
245 0 0 _aCXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study.
_h[electronic resource]
260 _bRheumatology (Oxford, England)
_cJan 2008
300 _a45-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aChemokine CCL2
_xblood
650 0 4 _aChemokine CXCL10
_xblood
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLongitudinal Studies
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aScleroderma, Systemic
_xblood
650 0 4 _aTime Factors
700 1 _aFerri, C
700 1 _aFallahi, P
700 1 _aFerrari, S M
700 1 _aGiuggioli, D
700 1 _aColaci, M
700 1 _aManfredi, A
700 1 _aFrascerra, S
700 1 _aFranzoni, F
700 1 _aGaletta, F
700 1 _aFerrannini, E
773 0 _tRheumatology (Oxford, England)
_gvol. 47
_gno. 1
_gp. 45-9
856 4 0 _uhttps://doi.org/10.1093/rheumatology/kem313
_zAvailable from publisher's website
999 _c17590798
_d17590798